Cargando…
Implementation and outcomes of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) monoclonal antibody treatment program at an academic medical center serving a high-risk patient population
Autores principales: | Borgetti, Scott A., Gross, Alan E., Kottler, Janey, Patel, Kenil, Paek, Jamie, Mena Lora, Alfredo J., Oikle, Diane, Jeffries, Delisa, Radosta, Jon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495403/ https://www.ncbi.nlm.nih.gov/pubmed/36168464 http://dx.doi.org/10.1017/ash.2021.165 |
Ejemplares similares
-
558. Implementation and Outcomes of a COVID-19 Monoclonal Antibody Treatment Program in an Urban Safety-net Community Hospital
por: Mena Lora, Alfredo J, et al.
Publicado: (2021) -
Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey
por: Mena Lora, Alfredo J., et al.
Publicado: (2023) -
Evaluation of the accuracy of a mandatory indication field for outpatient antibiotic prescriptions
por: Papanikolla, Johanna, et al.
Publicado: (2023) -
1199. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae: A Comparative Study Between Facilities in the United States and the Dominican Republic
por: Mena Lora, Alfredo J, et al.
Publicado: (2018) -
Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?
por: Mena Lora, Alfredo J., et al.
Publicado: (2023)